* 中国疫苗生产商--康希诺H股6185.HK周二早盘逆市最多涨14.4%，其A股688185.SS亦一度升5.6%。
* 该公司此前公告称，公司研发的DTcP-Hib-MCV4联合疫苗已获得中华人民共和国国家药品监督管理局批准，可以开展相关临床试验。
当前上证指数.SSEC和香港恒生指数.HSI均下跌。
* 康希诺H股今年迄今劲涨24.6%，同期恒生指数.HSI上扬15.2%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度跌3.1%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 田镧沁)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.